miR-185-5p alleviates the inflammatory response of acute gouty arthritis by inhibiting of IL-1β
Objective To investigate the relationship between interleukin-1β (IL-1β) and miR-185-5p in the process of joint injury in acute gouty arthritis (AGA). Methods The serum miR-185-5p levels of 89 AGA patients and 91 healthy volunteers were detected by real-time quantitative PCR. The correlation between miR-185-5p expression level and VAS score or IL-1β expression level was evaluated by Pearson correlation coefficient method. Receiver operating characteristic (ROC) curve was used to evaluate the diagnostic value of miR-185-5p in AGA. THP-1 cells were induced by sodium urate (MSU) to construct an in vitro acute gouty inflammatory cell model. After the expression level of miR-185-5p in THP-1 cells was upregulated or downregulated by transfection of miR-185-5p mimics or inhibitors in vitro, inflammatory cytokines of THP-1 cells, such as IL-1β, IL-8 and tumor necrosis factor α (TNF-α), were detected by ELISA. The luciferase reporter gene assay was used to determine the interaction between miR-185-5p and the 3'-UTR of IL-1β. Results Compared with the healthy control group, the expression level of serum miR-185-5p in AGA patients was significantly reduced. The level of serum miR-185-5p was negatively correlated with VAS score and IL-1β expression level. The area under the curve (AUC) was 0.905, the sensitivity was 80.17% and the specificity was 83.52%. Down-regulation of miR-185-5p significantly promoted the expression of IL-1β, IL-8 and tumor necrosis factor (TNF-α), while overexpression of miR-185-5p showed the opposite results. Luciferase reporter gene assay showed that IL-1β was the target gene of miR-185-5p, and miR-185-5p negatively regulated the expression of IL-1β. Conclusion miR-185-5p alleviates the inflammatory response in AGA by inhibiting IL-1β.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
---|---|
Enthalten in: |
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology - 40(2024), 1 vom: 21. Jan., Seite 51-57 |
Sprache: |
Chinesisch |
---|
Beteiligte Personen: |
Hou, Nan [VerfasserIn] |
---|
Themen: |
3' Untranslated Regions |
---|
Anmerkungen: |
Date Completed 29.01.2024 Date Revised 29.01.2024 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM367366711 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367366711 | ||
003 | DE-627 | ||
005 | 20240129232109.0 | ||
007 | tu | ||
008 | 240122s2024 xx ||||| 00| ||chi c | ||
028 | 5 | 2 | |a pubmed24n1274.xml |
035 | |a (DE-627)NLM367366711 | ||
035 | |a (NLM)38246177 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a chi | ||
100 | 1 | |a Hou, Nan |e verfasserin |4 aut | |
245 | 1 | 0 | |a miR-185-5p alleviates the inflammatory response of acute gouty arthritis by inhibiting of IL-1β |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 29.01.2024 | ||
500 | |a Date Revised 29.01.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Objective To investigate the relationship between interleukin-1β (IL-1β) and miR-185-5p in the process of joint injury in acute gouty arthritis (AGA). Methods The serum miR-185-5p levels of 89 AGA patients and 91 healthy volunteers were detected by real-time quantitative PCR. The correlation between miR-185-5p expression level and VAS score or IL-1β expression level was evaluated by Pearson correlation coefficient method. Receiver operating characteristic (ROC) curve was used to evaluate the diagnostic value of miR-185-5p in AGA. THP-1 cells were induced by sodium urate (MSU) to construct an in vitro acute gouty inflammatory cell model. After the expression level of miR-185-5p in THP-1 cells was upregulated or downregulated by transfection of miR-185-5p mimics or inhibitors in vitro, inflammatory cytokines of THP-1 cells, such as IL-1β, IL-8 and tumor necrosis factor α (TNF-α), were detected by ELISA. The luciferase reporter gene assay was used to determine the interaction between miR-185-5p and the 3'-UTR of IL-1β. Results Compared with the healthy control group, the expression level of serum miR-185-5p in AGA patients was significantly reduced. The level of serum miR-185-5p was negatively correlated with VAS score and IL-1β expression level. The area under the curve (AUC) was 0.905, the sensitivity was 80.17% and the specificity was 83.52%. Down-regulation of miR-185-5p significantly promoted the expression of IL-1β, IL-8 and tumor necrosis factor (TNF-α), while overexpression of miR-185-5p showed the opposite results. Luciferase reporter gene assay showed that IL-1β was the target gene of miR-185-5p, and miR-185-5p negatively regulated the expression of IL-1β. Conclusion miR-185-5p alleviates the inflammatory response in AGA by inhibiting IL-1β | ||
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 7 | |a 3' Untranslated Regions |2 NLM | |
650 | 7 | |a Interleukin-1beta |2 NLM | |
650 | 7 | |a Interleukin-8 |2 NLM | |
650 | 7 | |a Luciferases |2 NLM | |
650 | 7 | |a EC 1.13.12.- |2 NLM | |
650 | 7 | |a MicroRNAs |2 NLM | |
650 | 7 | |a MIRN185 microRNA, human |2 NLM | |
650 | 7 | |a Tumor Necrosis Factor-alpha |2 NLM | |
650 | 7 | |a IL1B protein, human |2 NLM | |
700 | 1 | |a Ma, Xianghui |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Wei |e verfasserin |4 aut | |
700 | 1 | |a Yuan, Min |e verfasserin |4 aut | |
700 | 1 | |a Xu, Liming |e verfasserin |4 aut | |
700 | 1 | |a Sun, Huanxia |e verfasserin |4 aut | |
700 | 1 | |a Liu, Yifan |e verfasserin |4 aut | |
700 | 1 | |a Liu, Lining |e verfasserin |4 aut | |
700 | 1 | |a Shi, Yanjun |e verfasserin |4 aut | |
700 | 1 | |a Li, Chunxian |e verfasserin |4 aut | |
700 | 1 | |a Fu, Yanfa |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology |d 2003 |g 40(2024), 1 vom: 21. Jan., Seite 51-57 |w (DE-627)NLM148235522 |x 1007-8738 |7 nnns |
773 | 1 | 8 | |g volume:40 |g year:2024 |g number:1 |g day:21 |g month:01 |g pages:51-57 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 40 |j 2024 |e 1 |b 21 |c 01 |h 51-57 |